SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of resTORbio, Inc. (NasdaqGS – TORC)

BALA CYNWYD – May 19, 2020 /Access Wire/ – Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of resTORbio, Inc. (“resTORbio”) (NasdaqGS – TORC) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the agreement to merge with Adicet Bio, Inc. (“Adicet”). Under the terms of the agreement, Adicet shareholders are expected to own approximately 75% of the combined company and resTORbio shareholders are expected to own only 25%.

If you own shares of resTORbio stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA 19004, or call toll free 877-534-2590.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.